Search

everythinglearnresearchcommunity

for

Search:↓

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Transverse scalp biopsy sections help diagnose different alopecias by showing hair follicle details and inflammation patterns.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Ectoparasites cause skin issues in Egyptian lesser blind mole rats, affecting their population.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hair papilla cells are crucial for blood vessel development in hair follicles, affecting hair growth and loss.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Hyaluronic acid successfully treated skin atrophy caused by corticosteroid injections.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Inflammation affects hair loss; anti-inflammatory treatments may help.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Two mouse mutations cause similar hair loss despite different skin changes.